|
LARP4B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62503344114384E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.7430501486615E-14 |
| Normal-vs-Stage2 |
2.27319999999143E-05 |
| Normal-vs-Stage3 |
2.02171612784241E-13 |
| Normal-vs-Stage4 |
1.45639944548748E-10 |
| Stage1-vs-Stage2 |
2.453800E-01 |
| Stage1-vs-Stage3 |
1.373240E-01 |
| Stage1-vs-Stage4 |
1.354980E-01 |
| Stage2-vs-Stage3 |
5.341800E-02 |
| Stage2-vs-Stage4 |
5.949500E-02 |
| Stage3-vs-Stage4 |
7.416800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.22044604925031E-16 |
| Normal-vs-AfricanAmerican |
1.438840E-03 |
| Normal-vs-Asian |
1.21590004731331E-09 |
| Caucasian-vs-AfricanAmerican |
5.947600E-02 |
| Caucasian-vs-Asian |
8.053000E-01 |
| AfricanAmerican-vs-Asian |
1.957370E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.27089999530017E-09 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
1.747210E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.19952961294712E-12 |
| Normal-vs-Age(41-60Yrs) |
2.74225087082414E-14 |
| Normal-vs-Age(61-80Yrs) |
3.49870021842946E-10 |
| Normal-vs-Age(81-100Yrs) |
3.795400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.244600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.684000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.903800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.127400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.637000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.443600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.018220E-02 |
| Classical-VS-Follicular |
4.279600E-02 |
| Classical-VS-Other |
8.598000E-01 |
| Classical-VS-Normal |
1.8650003763554E-10 |
| Tall-VS-Follicular |
4.577900E-04 |
| Tall-VS-Other |
1.519570E-01 |
| Tall-VS-Normal |
4.09339229179295E-12 |
| Follicular-VS-Other |
6.135200E-01 |
| Follicular-VS-Normal |
1.507810000001E-05 |
| Other-VS-Normal |
8.084000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.01739727753625E-11 |
| Normal-vs-N1 |
3.35790284466952E-11 |
| N0-vs-N1 |
5.651700E-02 |
|
|
